glp 1 and pancreas Cardiovascular, brain effects of GLP-1 GLP-1 | Pancreapedia

You may qualify if your BMI is 27 or higher with weight-related health factors, or 30 or higher without

Ongoing monitoring GLP-1 medications require follow-up

Existing extended-release options, like weekly formulations of semaglutide and dulaglutide, have reduced injection frequency, and future innovations may include monthly formulations or implantable devices that deliver continuous therapy

Early detection of thyroid abnormalities improves outcomes

Women who are planning long-term semaglutide use should be aware of this timeline and resist making permanent conclusions about their sexual function based on the first few months of treatment

On the other hand, it is still not entirely clear whether the hepatic effects of GLP-1 are direct or indirect, as recent studies have not clearly demonstrated the presence of GLP-1 receptors in human hepatocytes